Patient Guide: A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 87 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03462719
Status: ACTIVE_NOT_RECRUITING
Condition: Leukemia, Lymphocytic, Chronic, B-Cell
Phase: PHASE3

Find a Study Location Near You

This study is available at 87 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Louisville, Kentucky
  • Hackensack, New Jersey
  • Charlotte, North Carolina
  • • And 84 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily